Your browser doesn't support javascript.
loading
Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment.
Belcher, Annabelle M; Cole, Thomas O; Greenblatt, Aaron D; Hoag, Stephen W; Epstein, David H; Wagner, Michael; Billing, Amy S; Massey, Ebonie; Hamilton, Kristen R; Kozak, Zofia K; Welsh, Christopher J; Weintraub, Eric; Wickwire, Emerson M; Wish, Eric D; Kaptchuk, Ted J; Colloca, Luana.
Afiliação
  • Belcher AM; Department of Psychiatry, Division of Addiction Research and Treatment, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Cole TO; Department of Psychiatry, Division of Addiction Research and Treatment, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Greenblatt AD; Department of Psychiatry, Division of Addiction Research and Treatment, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Hoag SW; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • Epstein DH; Real-world Assessment, Prediction and Treatment Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland, USA.
  • Wagner M; University of Maryland Center for Substance Abuse Research, College Park, Maryland, USA.
  • Billing AS; University of Maryland Center for Substance Abuse Research, College Park, Maryland, USA.
  • Massey E; University of Maryland Center for Substance Abuse Research, College Park, Maryland, USA.
  • Hamilton KR; Department of Psychology, University of Maryland, College Park, Maryland, USA.
  • Kozak ZK; Medical School Training Program, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Welsh CJ; Department of Psychiatry, Division of Addiction Research and Treatment, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Weintraub E; Department of Psychiatry, Division of Addiction Research and Treatment, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Wickwire EM; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Wish ED; Sleep Disorders Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Kaptchuk TJ; University of Maryland Center for Substance Abuse Research, College Park, Maryland, USA.
  • Colloca L; Program in Placebo Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
BMJ Open ; 9(6): e026604, 2019 06 21.
Article em En | MEDLINE | ID: mdl-31230007
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento de Substituição de Opiáceos / Metadona / Antagonistas de Entorpecentes / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento de Substituição de Opiáceos / Metadona / Antagonistas de Entorpecentes / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article